Kamada (KMDA) Operating Income (2012 - 2026)

Kamada (KMDA) posted quarterly Operating Income of $7.0 million for Q1 2026, down 10.8% year-on-year from $7.8 million in Q1 2025, and down 17.55% on a QoQ basis from $8.4 million in Q4 2025.

Kamada (KMDA) Operating Income (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Operating Income for 15 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Operating Income fell 10.8% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 billion (up 57564.72% YoY) and the FY2025 annual result came in at $26.2 million, up 30.83% from the prior year.
  • Operating Income slipped to $7.0 million in Q1 2026 per KMDA's latest filing, from $8.4 million in the prior quarter.
  • Over the last five years, Operating Income for KMDA reached as high as $18.9 billion in Q2 2025 and fell as low as -$2.3 million in Q2 2022.
  • A 5-year average of $1.5 billion and a median of $7.8 million in 2025 frame the typical range for Operating Income.
  • Annual changes were most pronounced in 2022 — Operating Income sank 319.31% — and 2025, when it surged 335520.44%.
  • Year by year, Operating Income stood at $4.0 million in 2022, then tumbled by 30.91% to $2.8 million in 2023, then jumped by 247.41% to $9.6 million in 2024, then slipped by 12.56% to $8.4 million in 2025, then fell by 17.55% to $7.0 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered $7.0 million, $8.4 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 6.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.95 Mn
Dec 31, 2025 8.43 Mn
Sep 30, 2025 12.32 Mn
Jun 30, 2025 18.93 Bn
Mar 31, 2025 7.80 Mn
Dec 31, 2024 9.64 Mn
Sep 30, 2024 9.80 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 4.37 Bn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 289.00 Mn
Dec 31, 2022 4.02 Mn
Sep 30, 2022 2.56 Bn
Jun 30, 2022 -2.29 Mn
Mar 31, 2022 246,000.00
Dec 31, 2021 -3.30 Mn
Sep 30, 2021 -804,000.00
Jun 30, 2021 1.05 Mn